Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Investor Presentation

Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064 | ISIN: INE03QK01018 | Industry: Pharmaceuticals
| Expensive Underperformer

1080.5000 5.30 (0.49%)

NSE May 22, 2025 15:31 PM

80.69% Gain from 52W Low

Volume: 90,109

Cohance Lifesciences Ltd.

29 Feb 2024

1080.50

0.49%

Investor Presentation

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation

More from Cohance Lifescien…

All earning calls

Investor presentations from Cohance Lifescien…

All investor presentations